首页 > 最新文献

Ayu最新文献

英文 中文
Immunomodulatory activity of Swarna Prashana (oral administration of gold as electuary) in infants - A randomized controlled clinical trial. Swarna Prashana(口服黄金作为补剂)在婴儿中的免疫调节活性-一项随机对照临床试验。
Ayu
Pub Date : 2019-10-01 Epub Date: 2021-01-14 DOI: 10.4103/ayu.AYU_33_19
Jyothy Kothanath Bhaskaran, Kalpana Shantibhai Patel, Rajagopala Srikrishna

Background: Swarna Prashana (oral administration of gold as electuary) is a form of electuary depicted in the classics of Ayurveda under the ambit of pediatrics. A specific action on immune system has been highlighted in infants if gold is administered along with Ghrita and honey for a period of 28 days.

Aim: The present trial was conducted to assess the safety and efficacy of Swarna Bhasma (calcined powder), Madhu (honey) and Ghrita in infants with respect to anthropometrical, hematological and immunological parameters.

Methodology: The trial was a randomized, controlled, single-blind study in 102 healthy infants allocated into trial and control groups. Trial group received a mixture of Swarna Bhasma, honey and Ghrita, while control group received a mixture of honey and Ghrita, both in drops form for a period of 4 weeks with 8 weeks follow-up. Safety was assessed on the basis of biochemical parameters and efficacy was based on the values of IgG before and after the treatment.

Results: Anthropometrical and biochemical parameters did not showed any statistically significant difference between the effect of trial and control drugs, which suggested that the trial drugs did not hamper normal growth of the infants and were safe to be administered in infants. Both trial and control drugs showed statistically significant changes in IgG levels individually before and after the treatment; however, when compared between the groups, there was no significant differences. However, the number needed to treat (NNT) to assess the normalization of immunoglobulins, which is suggestive of its immunomodulatory activity, was 1 out of every 4.535 infants who received Swarna Prashana which was significant.

Conclusion: Swarna Prashana did not interfere with normal growth of the infants. As evident by NNT, it showed immunomodulatory activity and was tolerated by the infants with no adverse effects during the trial or follow-up period.

背景:Swarna Prashana(口服黄金作为补液)是阿育吠陀经典中在儿科范围内描述的一种补液形式。如果黄金与Ghrita和蜂蜜一起服用28天,对婴儿免疫系统的特殊作用已得到强调。目的:本试验旨在评估Swarna Bhasma(煅烧粉末)、Madhu(蜂蜜)和Ghrita在婴儿中的人体测量学、血流变学和免疫学参数的安全性和有效性。方法:该试验是一项随机、对照、单盲研究,将102名健康婴儿分为试验组和对照组。试验组给予Swarna Bhasma、蜂蜜和Ghrita的混合物,对照组给予蜂蜜和Ghrita的混合物,均为滴剂,为期4周,随访8周。以生化指标评价安全性,以治疗前后IgG值评价疗效。结果:试验药物与对照药物的人体测量和生化指标差异无统计学意义,说明试验药物不影响婴儿的正常生长,可安全用于婴儿。试验药物和对照药物治疗前后IgG水平变化均有统计学意义;然而,当组间比较时,没有显著差异。然而,需要治疗的数量(NNT)来评估免疫球蛋白的正常化,这表明其免疫调节活性,每4535名接受Swarna Prashana的婴儿中有1名需要治疗,这是显著的。结论:Swarna Prashana不影响婴儿的正常生长。正如NNT所证明的那样,它显示出免疫调节活性,并且在试验或随访期间被婴儿耐受,没有不良反应。
{"title":"Immunomodulatory activity of <i>Swarna Prashana</i> (oral administration of gold as electuary) in infants - A randomized controlled clinical trial.","authors":"Jyothy Kothanath Bhaskaran,&nbsp;Kalpana Shantibhai Patel,&nbsp;Rajagopala Srikrishna","doi":"10.4103/ayu.AYU_33_19","DOIUrl":"https://doi.org/10.4103/ayu.AYU_33_19","url":null,"abstract":"<p><strong>Background: </strong><i>Swarna</i> <i>Prashana</i> (oral administration of gold as electuary) is a form of electuary depicted in the classics of Ayurveda under the ambit of pediatrics. A specific action on immune system has been highlighted in infants if gold is administered along with <i>Ghrita</i> and honey for a period of 28 days.</p><p><strong>Aim: </strong>The present trial was conducted to assess the safety and efficacy of <i>Swarna Bhasma</i> (calcined powder), <i>Madhu</i> (honey) and <i>Ghrita</i> in infants with respect to anthropometrical, hematological and immunological parameters.</p><p><strong>Methodology: </strong>The trial was a randomized, controlled, single-blind study in 102 healthy infants allocated into trial and control groups. Trial group received a mixture of <i>Swarna</i> <i>Bhasma</i>, honey and <i>Ghrita</i>, while control group received a mixture of honey and <i>Ghrita</i>, both in drops form for a period of 4 weeks with 8 weeks follow-up. Safety was assessed on the basis of biochemical parameters and efficacy was based on the values of IgG before and after the treatment.</p><p><strong>Results: </strong>Anthropometrical and biochemical parameters did not showed any statistically significant difference between the effect of trial and control drugs, which suggested that the trial drugs did not hamper normal growth of the infants and were safe to be administered in infants. Both trial and control drugs showed statistically significant changes in IgG levels individually before and after the treatment; however, when compared between the groups, there was no significant differences. However, the number needed to treat (NNT) to assess the normalization of immunoglobulins, which is suggestive of its immunomodulatory activity, was 1 out of every 4.535 infants who received <i>Swarna Prashana</i> which was significant.</p><p><strong>Conclusion: </strong><i>Swarna Prashana</i> did not interfere with normal growth of the infants. As evident by NNT, it showed immunomodulatory activity and was tolerated by the infants with no adverse effects during the trial or follow-up period.</p>","PeriodicalId":8720,"journal":{"name":"Ayu","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/0e/a9/AYU-40-230.PMC8078605.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38872388","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
In vitro antioxidant activity of Erycibe paniculata Roxb. - An ethnomedicinal plant. 丹参体外抗氧化活性的研究。-民族药用植物。
Ayu
Pub Date : 2019-10-01 Epub Date: 2021-01-14 DOI: 10.4103/ayu.AYU_282_19
Minautee R Patel, Amit G Patel, Rakesh V Gamit, Mukesh Kumar B Nariya, Rabinarayan Acharya

Background: Erycibe paniculata Roxb. (Family-Convolvulaceae) has been reported for its potential ethno medicinal value. Leaf, stem, bark, and root of this plant are being used either single or in the mixture of the whole part in different disease conditions by different tribes.

Aims and objectives: The aim and objective of this study is to assess the antioxidant activity of methanolic extracts of different parts (leaf, stem, bark, and root) of Erycibe paniculata Roxb (E. paniculata).

Materials and methods: Different in-vitro assay such as free radical-scavenging assay by 2,2-diphenyl-1-picryl-hydrazyl-hydrate method, reducing power, super oxide radical scavenging, nitric oxide, and hydrogen peroxide scavenging assays were used to determine the antioxidant activity of different parts of E. paniculata. Ascorbic acid, sodium nitrite, and gallic acid were used as the standards for antioxidant activity.

Results: The percentage inhibition for all methods were plotted against different concentration and suggested that the obtained activities were concentration and dose depended. Inhibitory concentration (IC50) value of methanolic extract of leaf, stem, bark, and root of E. paniculata in different in vitro activities exhibited significant antioxidant activity. Methanolic extract of bark showed higher IC50 value in all antioxidant assays than other parts of E. paniculata.

Conclusion: Methanolic extract of leaf, stem, bark, and root of E. paniculata has potential antioxidant activity.

背景:丹参。(旋花科)因其潜在的民族药用价值而被报道。这种植物的叶、茎、皮和根在不同的疾病条件下被不同的部落单独使用或将整个部分混合使用。目的与目的:研究丹参不同部位(叶、茎、皮、根)甲醇提取物的抗氧化活性。材料与方法:采用2,2-二苯基-1-苦味基-水合肼法清除自由基、还原力、清除超氧化自由基、清除一氧化氮和清除过氧化氢等不同体外实验,测定了金合欢不同部位的抗氧化活性。以抗坏血酸、亚硝酸钠和没食子酸为抗氧化活性标准。结果:对不同浓度下各方法的抑制率进行了绘制,表明活性与浓度和剂量有关。叶、茎、皮、根甲醇提取物在不同体外活性下的抑菌浓度(IC50)值均表现出显著的抗氧化活性。各抗氧化指标中,树皮甲醇提取物的IC50值均高于其他部位。结论:金针叶、茎、皮、根甲醇提取物具有潜在的抗氧化活性。
{"title":"<i>In vitro</i> antioxidant activity of <i>Erycibe paniculata</i> Roxb. - An ethnomedicinal plant.","authors":"Minautee R Patel,&nbsp;Amit G Patel,&nbsp;Rakesh V Gamit,&nbsp;Mukesh Kumar B Nariya,&nbsp;Rabinarayan Acharya","doi":"10.4103/ayu.AYU_282_19","DOIUrl":"https://doi.org/10.4103/ayu.AYU_282_19","url":null,"abstract":"<p><strong>Background: </strong><i>Erycibe</i> <i>paniculata</i> Roxb. (Family-Convolvulaceae) has been reported for its potential ethno medicinal value. Leaf, stem, bark, and root of this plant are being used either single or in the mixture of the whole part in different disease conditions by different tribes.</p><p><strong>Aims and objectives: </strong>The aim and objective of this study is to assess the antioxidant activity of methanolic extracts of different parts (leaf, stem, bark, and root) of <i>Erycibe</i> <i>paniculata</i> Roxb <i>(E</i>. <i>paniculata)</i>.</p><p><strong>Materials and methods: </strong>Different <i>in-vitro</i> assay such as free radical-scavenging assay by 2,2-diphenyl-1-picryl-hydrazyl-hydrate method, reducing power, super oxide radical scavenging, nitric oxide, and hydrogen peroxide scavenging assays were used to determine the antioxidant activity of different parts of <i>E</i>. <i>paniculata</i>. Ascorbic acid, sodium nitrite, and gallic acid were used as the standards for antioxidant activity.</p><p><strong>Results: </strong>The percentage inhibition for all methods were plotted against different concentration and suggested that the obtained activities were concentration and dose depended. Inhibitory concentration (IC<sub>50</sub>) value of methanolic extract of leaf, stem, bark, and root of <i>E</i>. <i>paniculata</i> in different <i>in vitro</i> activities exhibited significant antioxidant activity. Methanolic extract of bark showed higher IC<sub>50</sub> value in all antioxidant assays than other parts of <i>E</i>. <i>paniculata</i>.</p><p><strong>Conclusion: </strong>Methanolic extract of leaf, stem, bark, and root of <i>E</i>. <i>paniculata</i> has potential antioxidant activity.</p>","PeriodicalId":8720,"journal":{"name":"Ayu","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/8c/67/AYU-40-256.PMC8078603.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38938180","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of Brihatyadi Yapana Basti and Shivalingi (Bryonia laciniosa Linn.) seed powder in the management of female infertility (Vandhyatva) due to anovulatory factor: An open-labelled randomized clinical trial. brhatyadi Yapana Basti和Shivalingi (Bryonia laciniosa Linn.)种子粉在治疗无排卵因素引起的女性不孕症(Vandhyatva)中的作用:一项开放标签随机临床试验。
Ayu
Pub Date : 2019-10-01 Epub Date: 2021-01-14 DOI: 10.4103/ayu.AYU_123_18
Gaurav Balat, Laxmipriya Dei, Shilpa Donga, Tarak Bhagora

Back ground: Infertility is a global problem that has impact on quality of life, especially through the negative psycho-social consequences. One-third of infertile population attending infertility clinics are reported with anovulation. According to Acharya Sushruta, among four essential factors required for conception, Beeja (ovum) is the core stone of the female reproductive process and conception can not be achieved in its absence, despite of other factors.

Aims and objectives: To evaluate and compare the efficacy of Brihatyadi Yapana Basti (therapeutic enema) and Shivalingi (Bryonia laciniosa Linn) seed powder in the management of female infertility w.s.r to the anovulatory factor.

Materials and methods: Total 30 female patients suffering from infertility due to anovulation confirmed by trans vaginal sonography were enrolled in the present study and randomly divided in two groups i.e., in group A (n = 15), Brihatyadi Yapana Basti (400 ml) was administered for 15 days after menstruation for 2 consecutive cycles. In group B (n = 15) Shivalingi seed powder was administered in dose of 3 gms twice in a day with cow milk on empty stomach for 2 months with 2 months followup. The efficacy of the therapy was assessed on the basis of follicular study by trans-vaginal sonography (TVS) on the 12th , 14th, 16th and 18th days of menstrual cycle and/or on the basis of conception achieved. The obtained data was analyzed for statistical significance using Student's t-test.

Result: In the Brihatyadi Yapana Basti group, ovulation was found in 80% of the patients and conception rate was 26.66% and in the Shivalingi seed powder oral group, ovulation was found in 64.28% patients and conception was not reported.

Conclusion: It was concluded that Brihatyadi Yapana Basti is more effective in follicular growth, ovulation and also achieving conception than that of Shivalingi seed powder orally.

背景:不孕不育是一个影响生活质量的全球性问题,特别是通过负面的心理和社会后果。据报道,三分之一的不孕症患者就诊于不孕症诊所。根据Acharya Sushruta的说法,在受孕所需的四个基本因素中,Beeja(卵子)是女性生殖过程的核心,没有它,尽管有其他因素,也无法受孕。目的与目的:评价和比较布氏灌肠剂和施瓦林基种子粉对女性不孕症的治疗效果。材料与方法:选取经阴道超声检查证实无排卵的女性不孕症患者30例,随机分为两组:A组(n = 15),月经后15天服用Brihatyadi Yapana Basti (400 ml),连续2个周期。B组(n = 15)采用牛乳空腹给药,每次3 g,每日2次,连续2个月,随访2个月。根据月经周期第12、14、16、18天经阴道超声(TVS)对卵泡的观察和/或受孕情况评估治疗的疗效。所得数据采用学生t检验进行统计学显著性分析。结果:布里哈帝亚帕那巴提组排卵率为80%,受孕率为26.66%;施伐林吉子散口服组排卵率为64.28%,未见受孕。结论:对卵泡生长、排卵及受孕的影响均优于口服湿婆林子粉。
{"title":"Effect of <i>Brihatyadi Yapana Basti</i> and <i>Shivalingi</i> (<i>Bryonia laciniosa</i> Linn.) seed powder in the management of female infertility (<i>Vandhyatva</i>) due to anovulatory factor: An open-labelled randomized clinical trial.","authors":"Gaurav Balat,&nbsp;Laxmipriya Dei,&nbsp;Shilpa Donga,&nbsp;Tarak Bhagora","doi":"10.4103/ayu.AYU_123_18","DOIUrl":"https://doi.org/10.4103/ayu.AYU_123_18","url":null,"abstract":"<p><strong>Back ground: </strong>Infertility is a global problem that has impact on quality of life, especially through the negative psycho-social consequences. One-third of infertile population attending infertility clinics are reported with anovulation. According to Acharya Sushruta, among four essential factors required for conception, <i>Beeja</i> (ovum) is the core stone of the female reproductive process and conception can not be achieved in its absence, despite of other factors.</p><p><strong>Aims and objectives: </strong>To evaluate and compare the efficacy of <i>Brihatyadi Yapana Basti</i> (therapeutic enema) and <i>Shivalingi</i> (<i>Bryonia laciniosa</i> Linn) seed powder in the management of female infertility w.s.r to the anovulatory factor.</p><p><strong>Materials and methods: </strong>Total 30 female patients suffering from infertility due to anovulation confirmed by trans vaginal sonography were enrolled in the present study and randomly divided in two groups i.e., in group A (<i>n</i> = 15), <i>Brihatyadi Yapana Basti</i> (400 ml) was administered for 15 days after menstruation for 2 consecutive cycles. In group B (<i>n</i> = 15) <i>Shivalingi</i> seed powder was administered in dose of 3 gms twice in a day with cow milk on empty stomach for 2 months with 2 months followup. The efficacy of the therapy was assessed on the basis of follicular study by trans-vaginal sonography (TVS) on the 12<sup>th</sup> , 14<sup>th</sup>, 16<sup>th</sup> and 18<sup>th</sup> days of menstrual cycle and/or on the basis of conception achieved. The obtained data was analyzed for statistical significance using Student's <i>t</i>-test.</p><p><strong>Result: </strong>In the <i>Brihatyadi Yapana Basti</i> group, ovulation was found in 80% of the patients and conception rate was 26.66% and in the <i>Shivalingi</i> seed powder oral group, ovulation was found in 64.28% patients and conception was not reported.</p><p><strong>Conclusion: </strong>It was concluded that <i>Brihatyadi Yapana Basti</i> is more effective in follicular growth, ovulation and also achieving conception than that of <i>Shivalingi</i> seed powder orally.</p>","PeriodicalId":8720,"journal":{"name":"Ayu","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/34/93/AYU-40-216.PMC8078601.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38872384","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Management of hypothyroidism by Kshara Basti (therapeutic enema)- A case report. 治疗性灌肠治疗甲状腺功能减退1例。
Ayu
Pub Date : 2019-10-01 Epub Date: 2021-01-14 DOI: 10.4103/ayu.AYU_297_18
Karishma Singh, Adil Rais, Anup B Thakar

Hypothyroidism is emerging as a common health concern in India as well as worldwide. An autoimmune cause accounts for approximately 90% of adult hypothyroidism mostly due to Hashimoto's disease. This autoimmunity goes parallel with the theory of Ama (intermediatory product) in Ayurveda. A case of a 27-year-old female patient, presenting with pain in multiple joints, deformity in the right little finger, morning stiffness lasting for more than 3 h, reduced appetite, constipation, and lethargy, diagnosed with Amavata (rheumatoid arthritis), was subclinically diagnosed with hypothyroidism and treated with Deepana (stimulates digestion), Pachana (promots digestion) and Koshtha Shuddhi (mild purgation) for 5 days followed by Kshara Basti (therapeutic enema) for 5 days. Reduction in serum- thyroid-stimulating hormone (S. TSH) (31.1 mIU/ml to 16.6 mIU/ml) along with relief in clinical manifestations of the disease was the outcome. Koshtha Shuddhi followed by Kshara Basti has its efficacy in hypothyroidism, as it not only improved signs and symptoms but S.TSH level was reduced significantly. This case report proposes an innovative treatment modality for the management of hypothyroidism, which needs to be validated through a well-planned study on a large sample size.

甲状腺功能减退症正在成为印度乃至全世界普遍关注的健康问题。自身免疫性疾病约占成人甲状腺功能减退的90%,主要由桥本氏病引起。这种自身免疫与阿育吠陀的Ama(中间产物)理论平行。1例27岁女性患者,以多关节疼痛,右小指畸形,晨僵持续3小时以上,食欲减退,便秘,嗜睡,诊断为Amavata(类风湿关节炎),亚临床诊断为甲状腺功能减退,分别用Deepana(刺激消化),Pachana(促进消化),Koshtha Shuddhi(轻度净化)治疗5天,Kshara Basti(治疗性灌肠)治疗5天。结果是血清促甲状腺激素(S. TSH)降低(31.1 mIU/ml至16.6 mIU/ml),同时疾病的临床表现得到缓解。kshtha Shuddhi继用Kshara Basti治疗甲状腺功能减退症,不仅改善了症状和体征,而且显著降低了S.TSH水平。本病例报告提出了一种治疗甲状腺功能减退的创新治疗方式,需要通过精心策划的大样本量研究来验证。
{"title":"Management of hypothyroidism by <i>Kshara Basti</i> (therapeutic enema)- A case report.","authors":"Karishma Singh,&nbsp;Adil Rais,&nbsp;Anup B Thakar","doi":"10.4103/ayu.AYU_297_18","DOIUrl":"https://doi.org/10.4103/ayu.AYU_297_18","url":null,"abstract":"<p><p>Hypothyroidism is emerging as a common health concern in India as well as worldwide. An autoimmune cause accounts for approximately 90% of adult hypothyroidism mostly due to Hashimoto's disease. This autoimmunity goes parallel with the theory of <i>Ama</i> (intermediatory product) in Ayurveda. A case of a 27-year-old female patient, presenting with pain in multiple joints, deformity in the right little finger, morning stiffness lasting for more than 3 h, reduced appetite, constipation, and lethargy, diagnosed with <i>Amavata</i> (rheumatoid arthritis), was subclinically diagnosed with hypothyroidism and treated with <i>Deepana</i> (stimulates digestion), <i>Pachana</i> (promots digestion) and <i>Koshtha</i> <i>Shuddhi</i> (mild purgation) for 5 days followed by <i>Kshara</i> <i>Basti</i> (therapeutic enema) for 5 days. Reduction in serum- thyroid-stimulating hormone (S. TSH) (31.1 mIU/ml to 16.6 mIU/ml) along with relief in clinical manifestations of the disease was the outcome. <i>Koshtha</i> <i>Shuddhi</i> followed by <i>Kshara</i> <i>Basti</i> has its efficacy in hypothyroidism, as it not only improved signs and symptoms but S.TSH level was reduced significantly. This case report proposes an innovative treatment modality for the management of hypothyroidism, which needs to be validated through a well-planned study on a large sample size.</p>","PeriodicalId":8720,"journal":{"name":"Ayu","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/1a/df/AYU-40-237.PMC8078602.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38872386","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The ACARA (Amrita Centre for Advanced Research in Ayurveda), Amrita School of Ayurveda and Indian Association for the Study of Traditional Asian Medicine (IASTAM) India (link is external), organised a Conclave on "Cancer Care and Research in AYUSH: Developing a Roadmap" from February 15-17, 2019. 阿育吠陀高级研究中心(ACARA)、阿育吠陀学院和印度传统亚洲医学研究协会(IASTAM)印度(link is external)于2019年2月15日至17日组织了一次关于“阿育吠陀癌症护理和研究:制定路线图”的秘密会议。
Ayu
Pub Date : 2019-07-01
{"title":"The ACARA (Amrita Centre for Advanced Research in Ayurveda), Amrita School of Ayurveda and Indian Association for the Study of Traditional Asian Medicine (IASTAM) India (link is external), organised a Conclave on \"Cancer Care and Research in AYUSH: Developing a Roadmap\" from February 15-17, 2019.","authors":"","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":8720,"journal":{"name":"Ayu","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/89/e0/AYU-40-1.PMC9757501.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10387431","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Strategies and avenues for COVID-19 - Ayurveda perception. 2019冠状病毒病的策略和途径——阿育吠陀感知。
Ayu
Pub Date : 2019-07-01 Epub Date: 2020-08-08 DOI: 10.4103/ayu.AYU_226_20
Mandip Goyal
Man has been facing many challenges from its existence; among them, issues related to health preservation and coping up with new diseases seems to be most concerned. To maintain quality of life and to live a long life that too without illness is a dream of every human being. To achieve this goal, efforts are being done time to time, but somehow due to enigmatic nature, changing environment, changed lifestyle, and demands of human, complete success in this regard is still to achieve. Ayurveda system of medicine encompasses health maintenance and preservation as its prime goal. Today, during the pandemic of COVID-19, this principle of healthy lifestyle has been endorsed as the important component of prevention and management of this disease.
{"title":"Strategies and avenues for COVID-19 - Ayurveda perception.","authors":"Mandip Goyal","doi":"10.4103/ayu.AYU_226_20","DOIUrl":"https://doi.org/10.4103/ayu.AYU_226_20","url":null,"abstract":"Man has been facing many challenges from its existence; among them, issues related to health preservation and coping up with new diseases seems to be most concerned. To maintain quality of life and to live a long life that too without illness is a dream of every human being. To achieve this goal, efforts are being done time to time, but somehow due to enigmatic nature, changing environment, changed lifestyle, and demands of human, complete success in this regard is still to achieve. Ayurveda system of medicine encompasses health maintenance and preservation as its prime goal. Today, during the pandemic of COVID-19, this principle of healthy lifestyle has been endorsed as the important component of prevention and management of this disease.","PeriodicalId":8720,"journal":{"name":"Ayu","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/9c/b9/AYU-40-139.PMC7685260.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38678517","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
An evaluation of the efficacy of ethanolic extract of Nigella sativa L. (Kalonji) on the clinical parameters of moderate‑to‑severe gingivitis: A split‑mouth clinical study. 黑草醇提物对中重度牙龈炎临床参数的影响评价:一项裂口临床研究。
Ayu
Pub Date : 2019-07-01 Epub Date: 2020-08-08 DOI: 10.4103/ayu.AYU_68_18
Vibha Singh, Abhaya Gupta, Umesh Pratap Verma, Tripti Mishra, Mahesh Pal

Introduction: Gingivitis is a relatively innocuous and reversible inflammation of gingiva. If left untreated, it might progress involving the deeper supporting periodontal tissues of the tooth with consequent mobility and tooth loss. Compelling literature has suggested the role of local antibacterial and anti‑inflammatory agents as an adjunct to scaling and root planing (gold standard) for treating periodontal diseases. Various herbs such as Nimba (Azadirachta indica A. Juss), Babbula (Vachellia nilotica (L.) P.J.H. Hurter & Mabb.) and turmeric (Curcuma longa L.) have been used for gingivitis since ancient times. Nigella sativa L. (Kalonji) is one such herb known for its remarkable anti‑inflammatory, antioxidant and antimicrobial properties and thus has been utilized in the present study.

Aim: The aim of the study was to explore the clinical efficacy of different ethanolic solutions of N. sativa in moderate‑to‑severe gingivitis patients.

Materials and methods: It is a split‑mouth clinical study with 24 patients of moderate‑to‑severe gingivitis from the age group of 25-45 years. Recruited individuals were divided in to group I1, group II1 and group III1 (scaling and root planning i.e., control) and group I2, group II2 and group III2 (experimental). Three doses of solution 1 (1:3), solution 2 (1:1) and solution 3 (3:1) were administered to the experimental groups for 3 consecutive days. The clinical parameters, i.e., gingival index (GI) and plaque index (PI) were recorded at baseline, 14 days and 28 days in all the individuals. ANOVA test was used in the study for statistical analysis.

Results: Intergroup comparison in terms of GI showed statistically significant difference at 14th and 28th day from baseline between I1 &I2, at only 28th day between II1 & II2 and insignificant difference between III1 & III2 at all time intervals from baseline. On intragroup comparison, statistically significant reduction in GI in all groups from baseline till 28 days was found, but among experimental groups best result was seen in group III2 (P < 0.001; F value 153.75). As far as PI is concerned, intergroup comparison between different groups displayed statistically significant difference from baseline to 14th and 28th day between all groups i.e I1& I2, II1& II2 and III1& III2. On intragroup comparison, statistically significant reduction in PI in all control groups i.e I1, II1 & III1 was found, but among experimental groups only group III2 provided statistically significant reduction (P < 0.001, F value 30.

牙龈炎是一种相对无害、可逆性的牙龈炎症。如果不及时治疗,它可能会发展到牙齿的深层牙周组织,从而导致牙齿的活动和脱落。令人信服的文献表明,局部抗菌和抗炎剂作为治疗牙周病的辅助手段,可用于洗牙和牙根刨(金标准)。各种草药,如印楝(Azadirachta indica A. Juss),巴巴拉(Vachellia nilotica (L.))。P.J.H. Hurter & Mabb)和姜黄(Curcuma longa L.)自古以来就被用于治疗牙龈炎。黑草(Nigella sativa L., Kalonji)就是其中一种以其显著的抗炎、抗氧化和抗菌特性而闻名的草药,因此在本研究中被利用。目的:探讨不同乙醇溶液对中重度牙龈炎患者的临床疗效。材料和方法:这是一项分口临床研究,24例年龄在25-45岁的中重度牙龈炎患者。将入选个体分为I1组、II1组和III1组(除垢和根规划即对照组)和I2组、II2组和III2组(实验组)。实验组按溶液1(1:3)、溶液2(1:1)、溶液3(3:1)三种剂量连续给予3 d。记录所有个体在基线、14天和28天的临床参数牙龈指数(GI)和菌斑指数(PI)。本研究采用方差分析进行统计分析。结果:组间比较,I1与i2在距基线14天、28天有统计学差异,II1与II2仅在距基线28天有统计学差异,III1与III2在距基线各时间间隔均无统计学差异。组内比较,各组从基线至28 d的GI下降均有统计学意义,但试验组中以ii2组效果最好(P < 0.001;F值153.75)。在PI方面,不同组间比较,I1& I2、II1& II2、III1& III2组间比较,从基线到第14、28天,差异均有统计学意义。组内比较,I1、II1、II1 3个对照组PI均有统计学意义降低,实验组间仅III2组PI有统计学意义降低(P < 0.001, F值30.40)。结论:芥蓝乙醇提取物对中重度牙龈炎有较好的治疗作用。
{"title":"An evaluation of the efficacy of ethanolic extract of <i>Nigella sativa</i> L. (<i>Kalonji</i>) on the clinical parameters of moderate‑to‑severe gingivitis: A split‑mouth clinical study.","authors":"Vibha Singh,&nbsp;Abhaya Gupta,&nbsp;Umesh Pratap Verma,&nbsp;Tripti Mishra,&nbsp;Mahesh Pal","doi":"10.4103/ayu.AYU_68_18","DOIUrl":"https://doi.org/10.4103/ayu.AYU_68_18","url":null,"abstract":"<p><strong>Introduction: </strong>Gingivitis is a relatively innocuous and reversible inflammation of gingiva. If left untreated, it might progress involving the deeper supporting periodontal tissues of the tooth with consequent mobility and tooth loss. Compelling literature has suggested the role of local antibacterial and anti‑inflammatory agents as an adjunct to scaling and root planing (gold standard) for treating periodontal diseases. Various herbs such as <i>Nimba</i> (<i>Azadirachta indica</i> A. Juss), <i>Babbula</i> (<i>Vachellia nilotica</i> (L.) P.J.H. Hurter & Mabb.) and turmeric (<i>Curcuma long</i>a L.) have been used for gingivitis since ancient times. <i>Nigella sativa</i> L. (<i>Kalonji</i>) is one such herb known for its remarkable anti‑inflammatory, antioxidant and antimicrobial properties and thus has been utilized in the present study.</p><p><strong>Aim: </strong>The aim of the study was to explore the clinical efficacy of different ethanolic solutions of <i>N. sativa</i> in moderate‑to‑severe gingivitis patients.</p><p><strong>Materials and methods: </strong>It is a split‑mouth clinical study with 24 patients of moderate‑to‑severe gingivitis from the age group of 25-45 years. Recruited individuals were divided in to group I<sub>1</sub>, group II<sub>1</sub> and group III<sub>1</sub> (scaling and root planning i.e., control) and group I<sub>2</sub>, group II<sub>2</sub> and group III<sub>2</sub> (experimental). Three doses of solution 1 (1:3), solution 2 (1:1) and solution 3 (3:1) were administered to the experimental groups for 3 consecutive days. The clinical parameters, i.e., gingival index (GI) and plaque index (PI) were recorded at baseline, 14 days and 28 days in all the individuals. ANOVA test was used in the study for statistical analysis.</p><p><strong>Results: </strong>Intergroup comparison in terms of GI showed statistically significant difference at 14<sup>th</sup> and 28<sup>th</sup> day from baseline between I<sub>1 &</sub>I<sub>2,</sub> at only 28<sup>th</sup> day between II<sub>1</sub> & II<sub>2</sub> and insignificant difference between III<sub>1</sub> & III<sub>2</sub> at all time intervals from baseline. On intragroup comparison, statistically significant reduction in GI in all groups from baseline till 28 days was found, but among experimental groups best result was seen in group III<sub>2</sub> (<i>P</i> < 0.001; F value 153.75). As far as PI is concerned, intergroup comparison between different groups displayed statistically significant difference from baseline to 14<sup>th</sup> and 28<sup>th</sup> day between all groups i.e I<sub>1</sub>& I<sub>2</sub>, II<sub>1</sub>& II<sub>2</sub> and III<sub>1</sub>& III<sub>2</sub>. On intragroup comparison, statistically significant reduction in PI in all control groups i.e I<sub>1,</sub> II<sub>1</sub> & III<sub>1</sub> was found, but among experimental groups only group III<sub>2</sub> provided statistically significant reduction (<i>P</i> < 0.001, F value 30.","PeriodicalId":8720,"journal":{"name":"Ayu","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/15/bf/AYU-40-152.PMC7685263.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38678519","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 9
Macro‑micro‑morphological diagnosis of leaves of two species of Cinnamomum (C. sulphuratum and C. verum) used as resource of bay leaf. 作为月桂叶资源的两种肉桂(C. suluratum和C. verum)叶片的宏微观形态诊断。
Ayu
Pub Date : 2019-07-01 Epub Date: 2020-08-08 DOI: 10.4103/ayu.AYU_194_17
Sunil Kumar Koppala Narayana, Divya Kallingilkalathil Gopi, Mattummal Rubeena, Sathiya Rajeswaran Parameswaran

Background: Cinnamomum verum (true cinnamon or Tejpatra) is a well‑known spice with immense medicinal properties. Its adulteration with leaf and bark of other species belonging to genus Cinnamomum is found to be a common practice in India.

Aims: Cinnamomum sulphuratum is used as a substitute of C. verum owing to its apparent macroscopic similarities.

Materials and methods: Fresh leaves of C. verum and C. sulphuratum growing in South India were collected and studied to establish their macro-microscopic identity with pharmacognostical perspective.

Results: Detailed microscopic evaluation by transverse section, maceration, and powder microscopy was conducted to delineate the two species. Detailed macroscopic identification served the purpose of identification of the entire drug on the spot, and microscopy has helped in the identification of fragmented and powdered form of the drugs.

Conclusion: Further chemical and biological studies may be necessary to confirm whether these leaves can be used as a substitute or adulterant for other species Cinnamon.

背景:肉桂(真正的肉桂或Tejpatra)是一种众所周知的香料,具有巨大的药用价值。它掺假叶子和树皮的其他物种属于肉桂属被发现是一种常见的做法在印度。目的:磺化肉桂因其具有明显的宏观相似性而被用作verum的替代品。材料与方法:从生药学角度对生长于南印度的verum和c.s uluratum的新鲜叶片进行了宏观显微镜下的鉴别研究。结果:通过横切面,浸渍和粉末显微镜进行了详细的显微镜评估,以描绘两个物种。详细的宏观鉴定服务于现场鉴定整个药物的目的,显微镜有助于鉴定药物的碎片状和粉末状。结论:肉桂叶是否可以作为其他肉桂的替代品或掺假物,需要进一步的化学和生物学研究。
{"title":"Macro‑micro‑morphological diagnosis of leaves of two species of <i>Cinnamomum</i> (<i>C. sulphuratum</i> and <i>C. verum</i>) used as resource of bay leaf.","authors":"Sunil Kumar Koppala Narayana,&nbsp;Divya Kallingilkalathil Gopi,&nbsp;Mattummal Rubeena,&nbsp;Sathiya Rajeswaran Parameswaran","doi":"10.4103/ayu.AYU_194_17","DOIUrl":"https://doi.org/10.4103/ayu.AYU_194_17","url":null,"abstract":"<p><strong>Background: </strong><i>Cinnamomum</i> <i>verum</i> (true cinnamon or <i>Tejpatra</i>) is a well‑known spice with immense medicinal properties. Its adulteration with leaf and bark of other species belonging to genus <i>Cinnamomum</i> is found to be a common practice in India.</p><p><strong>Aims: </strong><i>Cinnamomum</i> <i>sulphuratum</i> is used as a substitute of <i>C</i>. <i>verum</i> owing to its apparent macroscopic similarities.</p><p><strong>Materials and methods: </strong>Fresh leaves of <i>C</i>. <i>verum</i> and <i>C. sulphuratum</i> growing in South India were collected and studied to establish their macro-microscopic identity with pharmacognostical perspective.</p><p><strong>Results: </strong>Detailed microscopic evaluation by transverse section, maceration, and powder microscopy was conducted to delineate the two species. Detailed macroscopic identification served the purpose of identification of the entire drug on the spot, and microscopy has helped in the identification of fragmented and powdered form of the drugs.</p><p><strong>Conclusion: </strong>Further chemical and biological studies may be necessary to confirm whether these leaves can be used as a substitute or adulterant for other species <i>Cinnamon</i>.</p>","PeriodicalId":8720,"journal":{"name":"Ayu","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/a7/f1/AYU-40-196.PMC7685258.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38680188","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Therapeutic influence of some dietary articles on gut microbiota in the pathogenesis of rheumatoid arthritis (Amavata) - A review. 一些膳食对类风湿关节炎发病过程中肠道微生物群的治疗作用(Amavata)综述。
Ayu
Pub Date : 2019-07-01 Epub Date: 2020-08-08 DOI: 10.4103/ayu.AYU_192_19
Y S Aswathy, P V Anandaraman

Background: Amavata is a chronic immune‑inflammatory systemic disorder caused by the formation of Ama and its association with Vata at Kaphasthana (joints) and can be simulated with rheumatoid arthritis (RA). Published evidences show that treatment indicated in Amavata is effective in RA. Increased inflammatory status in RA is suggestive of gut dysbiosis involving gut microbiota (GM).

Aim: The aim of the present study was to analyze the influence of diet on GM of RA patients based on Pathya (dietary advice) mentioned for Amavata.

Materials and methods: Laghutrayis such as Bhavaprakasha Samhita, Madhava Nidana and Sharangadhara Samhita, Bhaishajya Ratnavali and Nighantus (Sanskrit glossary) such as Raja Nighantu, Bhavaprakasha Nighantu and Yogaratnakara, Ashtanga Hridaya also different databases were reviewed for Pathya of Amavata. Different databases such as PubMed, Scopus, DHARA, Google Scholar, Science Direct were searched with research papers establishing the role of nonnutritive bioactive components in horse gram, barley, garlic, ginger, drumstick leaves, cow urine and buttermilk in the management of RA were also reviewed. It was found that Pathya influences on the GM by lowering or inhibiting inflammatory markers such as interleukin‑6 (IL‑6), 17 and leukotrines through Bowman‑Birk inhibitors and polyphenolic compounds. Among them, Takra is already a proven probiotic. Gomutra augments B and T lymphocytes, IL‑1 and IL‑2, strengthening the immune system.

Conclusion: It was concluded that Pathya Ahara mentioned for Amavata have a direct link with GM of RA patients. Even though the pharmacological actions have been clinically proven/practised, this review creates evidence for its scientific basis.

背景:Amavata是一种慢性免疫炎性全身性疾病,由Ama的形成及其与Kaphasthana(关节)的Vata相关引起,可与类风湿关节炎(RA)模拟。已发表的证据表明,Amavata所指示的治疗对RA有效。RA中炎症状态的增加提示涉及肠道微生物群(GM)的肠道生态失调。目的:本研究的目的是根据Amavata所提到的Pathya(饮食建议)分析饮食对RA患者GM的影响。材料与方法:对《阿玛瓦塔》中的《巴瓦拉卡沙》、《Madhava尼达那》和《Sharangadhara尼达那》等Laghutrayis,《巴瓦拉卡沙尼达那》和《尼伽拉那那》等梵语词汇,以及《阿玛瓦塔之路》等不同的数据库进行了检索。检索PubMed、Scopus、DHARA、Google Scholar、Science Direct等数据库,对马克、大麦、大蒜、生姜、鸡腿叶、牛尿和酪乳中非营养性生物活性成分在RA治疗中的作用进行综述。发现Pathya通过Bowman - Birk抑制剂和多酚类化合物降低或抑制炎症标志物,如白细胞介素- 6 (IL - 6)、17和白蛋白,从而影响GM。其中,Takra已经被证明是一种益生菌。Gomutra增强B淋巴细胞和T淋巴细胞,IL - 1和IL - 2,增强免疫系统。结论:Amavata中提到的Pathya Ahara与RA患者GM有直接关系。尽管药理作用已被临床证明/实践,但本综述为其科学基础提供了证据。
{"title":"Therapeutic influence of some dietary articles on gut microbiota in the pathogenesis of rheumatoid arthritis (<i>Amavata</i>) - A review.","authors":"Y S Aswathy,&nbsp;P V Anandaraman","doi":"10.4103/ayu.AYU_192_19","DOIUrl":"https://doi.org/10.4103/ayu.AYU_192_19","url":null,"abstract":"<p><strong>Background: </strong><i>Amavata</i> is a chronic immune‑inflammatory systemic disorder caused by the formation of <i>Ama</i> and its association with <i>Vata</i> at <i>Kaphasthana</i> (joints) and can be simulated with rheumatoid arthritis (RA). Published evidences show that treatment indicated in <i>Amavata</i> is effective in RA. Increased inflammatory status in RA is suggestive of gut dysbiosis involving gut microbiota (GM).</p><p><strong>Aim: </strong>The aim of the present study was to analyze the influence of diet on GM of RA patients based on <i>Pathya</i> (dietary advice) mentioned for <i>Amavata</i>.</p><p><strong>Materials and methods: </strong>Laghutrayis such as Bhavaprakasha Samhita, Madhava Nidana and Sharangadhara Samhita, Bhaishajya Ratnavali and Nighantus (Sanskrit glossary) such as Raja Nighantu, Bhavaprakasha Nighantu and Yogaratnakara, Ashtanga Hridaya also different databases were reviewed for <i>Pathya</i> of <i>Amavata</i>. Different databases such as PubMed, Scopus, DHARA, Google Scholar, Science Direct were searched with research papers establishing the role of nonnutritive bioactive components in horse gram, barley, garlic, ginger, drumstick leaves, cow urine and buttermilk in the management of RA were also reviewed. It was found that <i>Pathya</i> influences on the GM by lowering or inhibiting inflammatory markers such as interleukin‑6 (IL‑6), 17 and leukotrines through Bowman‑Birk inhibitors and polyphenolic compounds. Among them, <i>Takra</i> is already a proven probiotic. <i>Gomutra</i> augments B and T lymphocytes, IL‑1 and IL‑2, strengthening the immune system.</p><p><strong>Conclusion: </strong>It was concluded that <i>Pathya</i> <i>Ahara</i> mentioned for <i>Amavata</i> have a direct link with GM of RA patients. Even though the pharmacological actions have been clinically proven/practised, this review creates evidence for its scientific basis.</p>","PeriodicalId":8720,"journal":{"name":"Ayu","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/de/db/AYU-40-147.PMC7685262.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38689820","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
A clinical study on Virechana Karma (therapeutic purgation) over the gut flora with special reference to obesity. 对肠道菌群进行 Virechana Karma(治疗性净化)的临床研究,特别是肥胖症。
Ayu
Pub Date : 2019-07-01 Epub Date: 2020-08-08 DOI: 10.4103/ayu.AYU_302_19
Ashutosh Chaturvedi, Gopal Nath, Virender Bhadur Yadav, Meera Antiwal, Niharika Shakya, C Swathi, Jai Prakash Singh

Background: Altered gut flora is associated with the pathogenesis of both intestinal and extra‑intestinal disorders. Aetiology of obesity is associated with mechanisms such as short chain fatty acid production, stimulation of hormones, chronic low‑grade inflammation, lipoprotein and bile acid metabolism and increased endocannabinoid. Receptor system tone have been suggested to explain the role of gut microbiota of obesity. The Panchakarma (Ayurvedic purification methods) claims the management of metabolic disorders hence this work provides the target specific evidence for the clinical studies. The proposed project is aimed to explore the particular molecular mechanism and, to make this therapy more evidence based. Hence, it was hypothesized that Panchakarma‑based intervention such as Virechana Karma (therapeutic purgation) may influence microbiota and help in the management of the obesity.

Materials and methods: The study was conducted to explore the effect of Virechana Karma over the gut flora; therefore, total of 19 patients with Madhyama Koshtha diagnosed with obesity were included and received the intervention. Before and after Virechana, a stool sample was collected and processed for the enterobacterial repetitive intergenic consensus ‑polymerase chain reaction to find the changes over the facultative aerobic bacteria.

Results: It was found that Virechana is effective in the management of the obesity as it helps to reduce colonization of aerobic bacteria. After Virechana and after follow‑up also, it showed the correction of the gut flora dysbiosis, thus initiated the weight loss mechanism in the body, resulting in diminution in the signs and symptoms of obesity.

Conclusion: Virechana is effective in the management of the obesity due to reduction in the Escherichia coli colonization and is effective over the gut flora dysbiosis.

背景:肠道菌群的改变与肠道和肠道外疾病的发病机制有关。肥胖症的病因与短链脂肪酸生成、激素刺激、慢性低度炎症、脂蛋白和胆汁酸代谢以及内源性大麻素增加等机制有关。有人认为,受体系统的调节作用可以解释肠道微生物群在肥胖症中的作用。Panchakarma(阿育吠陀净化方法)声称可以治疗代谢紊乱,因此这项工作为临床研究提供了目标明确的证据。拟议的项目旨在探索特定的分子机制,使这种疗法更有依据。因此,我们假设以潘查卡玛疗法(Panchakarma)为基础的干预措施,如 Virechana Karma(治疗性净化),可能会影响微生物群,并有助于肥胖症的治疗:本研究旨在探讨 Virechana Karma 对肠道菌群的影响,因此共纳入了 19 名被诊断为肥胖症的 Madhyama Koshtha 患者,他们都接受了干预。在接受 Virechana 之前和之后,采集粪便样本并进行肠道细菌重复基因间共识聚合酶链反应,以发现兼性需氧菌的变化:结果:研究发现,Virechana 能有效控制肥胖症,因为它有助于减少需氧菌的定植。经过 Virechana 和后续治疗后,肠道菌群失调得到了纠正,从而启动了体内减肥机制,减少了肥胖的症状和体征:结论:Virechana 能有效控制肥胖症,因为它能减少大肠埃希氏菌的定植,并对肠道菌群失调有效。
{"title":"A clinical study on <i>Virechana Karma</i> (therapeutic purgation) over the gut flora with special reference to obesity.","authors":"Ashutosh Chaturvedi, Gopal Nath, Virender Bhadur Yadav, Meera Antiwal, Niharika Shakya, C Swathi, Jai Prakash Singh","doi":"10.4103/ayu.AYU_302_19","DOIUrl":"10.4103/ayu.AYU_302_19","url":null,"abstract":"<p><strong>Background: </strong>Altered gut flora is associated with the pathogenesis of both intestinal and extra‑intestinal disorders. Aetiology of obesity is associated with mechanisms such as short chain fatty acid production, stimulation of hormones, chronic low‑grade inflammation, lipoprotein and bile acid metabolism and increased endocannabinoid. Receptor system tone have been suggested to explain the role of gut microbiota of obesity. The <i>Panchakarma</i> (Ayurvedic purification methods) claims the management of metabolic disorders hence this work provides the target specific evidence for the clinical studies. The proposed project is aimed to explore the particular molecular mechanism and, to make this therapy more evidence based. Hence, it was hypothesized that <i>Panchakarma</i>‑based intervention such as <i>Virechana Karma</i> (therapeutic purgation) may influence microbiota and help in the management of the obesity.</p><p><strong>Materials and methods: </strong>The study was conducted to explore the effect of <i>Virechana</i> <i>Karma</i> over the gut flora; therefore, total of 19 patients with <i>Madhyama</i> <i>Koshtha</i> diagnosed with obesity were included and received the intervention. Before and after <i>Virechana</i>, a stool sample was collected and processed for the enterobacterial repetitive intergenic consensus ‑polymerase chain reaction to find the changes over the facultative aerobic bacteria.</p><p><strong>Results: </strong>It was found that <i>Virechana</i> is effective in the management of the obesity as it helps to reduce colonization of aerobic bacteria. After <i>Virechana</i> and after follow‑up also, it showed the correction of the gut flora dysbiosis, thus initiated the weight loss mechanism in the body, resulting in diminution in the signs and symptoms of obesity.</p><p><strong>Conclusion: </strong><i>Virechana</i> is effective in the management of the obesity due to reduction in the <i>Escherichia coli</i> colonization and is effective over the gut flora dysbiosis.</p>","PeriodicalId":8720,"journal":{"name":"Ayu","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/db/dd/AYU-40-179.PMC7685265.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38689824","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Ayu
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1